On Cancer

Filter by Tag

Honor

Structural Biologist Christopher Lima Named Howard Hughes Medical Institute Investigator

By Esther Napolitano, BS, Science Writer/Editor | Thursday, May 9, 2013

Dr. Lima is one of 27 biomedical researchers in the country being named an HHMI investigator today. This elite group of scientists will receive approximately $150 million over the next five years.

Tags: Structural Biology; Research

Pictured: Robert Motzer & Suzanne Gornell

Video

Physicians and Scientists at Memorial Sloan-Kettering Pioneer the Development of Kidney Cancer Treatments

By Allyson Collins, MS, Science Writer/Editor | Wednesday, May 8, 2013

Our experts have participated in or led the development of five of the seven drugs approved by the US Food and Drug Administration for patients with advanced kidney cancer since 2005.

Tags: Cancer Care; Clinical Trials; Targeted Therapy; Treatment; Kidney Cancer; Research

In the Lab

Large Genetic Study Could Improve Endometrial Cancer Diagnosis and Treatment

By Jim Stallard, MA, Writer/Editor | Wednesday, May 1, 2013

An analysis of endometrial cancers reveals genetic information that should improve diagnosis and guide treatments for women with an aggressive form of the disease.

Tags: Cancer Care; Cancer Genetics; Endometrial Cancer; Research

In the Lab

Research Suggests a New Approach for Overcoming Resistance to a Targeted Therapy for Prostate Cancer

By Julie Grisham, MS, Science Writer/Editor | Tuesday, April 30, 2013

Research suggests that a new drug could be effective in patients with prostate cancer who develop resistance to the targeted therapy enzalutamide.

Tags: Cancer Biology; Cancer Care; Drug Discovery; Targeted Therapy; Prostate Cancer; Research

Profile

At Work: Physician-Scientist Liang Deng

By Jim Stallard, MA, Writer/Editor | Friday, April 26, 2013

Physician-scientist Liang Deng cares for patients with melanoma and other skin cancers, and also conducts innovative research on poxviruses.

Tags: Cancer Biology; Immunology; Treatment; Melanoma; Research

In the Clinic

Studies Show Promise for Treatment Advances in Several Types of Sarcoma

By Julie Grisham, MS, Science Writer/Editor | Monday, April 22, 2013

Two clinical trials of targeted therapies led by Memorial Sloan-Kettering investigators show promising results against different types of sarcoma.

Tags: Cancer Care; Clinical Trials; Bone Cancer; Targeted Therapy; Treatment; Soft Tissue Sarcoma; Research

Finding

A Single Early PSA Test Found to Predict Long-Term Risk of Aggressive Prostate Cancer

By Allyson Collins, MS, Science Writer/Editor | Wednesday, April 17, 2013

A study led by Memorial Sloan-Kettering investigators indicates nearly half of all prostate cancer deaths by age 75 occur in a small group of men with high PSA levels at age 45.

Tags: Cancer Care; PSA Testing; Diagnosis; Screening; Prostate Cancer; Research

Video

Meet Leukemia Expert Dan Douer

By Memorial Sloan-Kettering | Wednesday, April 10, 2013

Dr. Douer, leader of the research program in acute lymphoblastic leukemia, talks about how patients are treated by a caring team that includes physicians, nurses, social workers, and support staff.

Tags: Cancer Care; Treatment; Leukemias; Research

Finding

Studies Report on Latest Advances in Targeted Therapy for Breast Cancer

By Julie Grisham, MS, Science Writer/Editor | Monday, April 8, 2013

Memorial Sloan-Kettering’s Physician-in-Chief, José Baselga, explains the findings from three studies on new targeted therapies for breast cancer.

Tags: Cancer Care; Clinical Trials; Targeted Therapy; Breast Cancer; Research

In the Clinic

Combining Two FDA-Approved Drugs May Be Harmful for Patients with Metastatic Melanoma

By Media Staff | Thursday, April 4, 2013

Early research led by investigators at Memorial Sloan-Kettering cautions against combining ipilimumab and vemurafenib for the treatment of metastatic melanoma.

Tags: Cancer Care; Clinical Trials; Immunotherapy; Treatment; Melanoma; Research

Q&A

Increased Emphasis on Clinical Research to Advance Cancer Treatment

By Media Staff | Tuesday, April 2, 2013

In his new role as Deputy Physician-in-Chief for Clinical Research, Paul Sabbatini aims to streamline, accelerate, and expand Memorial Sloan-Kettering’s clinical research program.

Tags: Cancer Care; Clinical Trials; Personalized Medicine; Research

Finding

New Findings May Lead to Better Predictions of Breast Cancer Risk in Women with Inherited Mutations

By Julie Grisham, MS, Science Writer/Editor | Thursday, March 28, 2013

A study identifies genetic variations that alter the risk of breast cancer in women who have a certain gene mutation.

Tags: Cancer Care; Cancer Genetics; Breast Cancer; Screening; Research

Event

Cycle for Survival Raises Record Funds for Rare Cancer Research

By Jim Stallard, MA, Writer/Editor | Monday, March 25, 2013

The indoor cycling fund-raiser, in its seventh year, has raised more than $31 million for rare cancer research at Memorial Sloan-Kettering.

Tags: Fundraising; Giving; Research

Pictured: Isabelle Rivière, Michel Sadelain & Renier Brentjens

In the Clinic

Cell-Based Immune Therapy Shows Promise in Leukemia Patients

By Jim Stallard, MA, Writer/Editor | Wednesday, March 20, 2013

Memorial Sloan-Kettering researchers have used genetically modified immune cells to eradicate cancer in five patients with acute lymphoblastic leukemia.

Tags: Cancer Care; Clinical Trials; Cell Engineering; Experimental Therapeutics; Leukemias; Research

In the Lab

New Molecule Targets Proteins Inside Cancer Cells

By Julie Grisham, MS, Science Writer/Editor | Wednesday, March 13, 2013

Scientists from Memorial Sloan-Kettering have collaborated on the discovery of a unique monoclonal antibody, called ESK1, that appears to be effective at targeting and destroying several types of cancer cells.

Tags: Targeted Therapy; Molecular Pharmacology; Leukemias; Research